Literature DB >> 26892995

New Cholesterol Guidelines for the Management of Atherosclerotic Cardiovascular Disease Risk: A Comparison of the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines with the 2014 National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia.

Bhavin B Adhyaru1, Terry A Jacobson2.   

Abstract

This review discusses the 2013 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults and compares it with the 2014 National Lipid Association (NLA) Recommendations for Patient-Centered Management of Dyslipidemia. The review discusses some of the distinctions between the guidelines, including how to determine a patient's atherosclerotic cardiovascular disease risk, the role of lipoprotein treatment targets, the importance of moderate- and high-intensity statin therapy, and the use of nonstatin therapy in light of the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) trial.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherogenic cholesterol; Atherosclerotic cardiovascular disease (ASCVD); Clinical recommendations; Dyslipidemia; Guidelines; Low-density lipoprotein cholesterol (LDL-C)

Year:  2016        PMID： 26892995     DOI： 10.1016/j.ecl.2015.09.002

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  7 in total

1.  The Potential of the Marine Microalga Diacronema lutheri in the Prevention of Obesity and Metabolic Syndrome in High-Fat-Fed Wistar Rats.

Authors:  Claire Mayer; Martine Côme; Lionel Ulmann; Isabelle Martin; Graziella Chini Zittelli; Cecilia Faraloni; Khadija Ouguerram; Benoît Chénais; Virginie Mimouni
Journal:  Molecules       Date:  2022-06-30       Impact factor: 4.927

2.  Prognostic value of coronary atherosclerosis progression evaluated by coronary CT angiography in patients with stable angina.

Authors:  Hui Gu; Yang Gao; Zhihui Hou; U Joseph Schoepf; Alan N Snyder; Taylor M Duguay; Ximing Wang; Bin Lu
Journal:  Eur Radiol       Date:  2017-09-29       Impact factor: 5.315

Review 3.  Clinical considerations of lipid target and goal in dyslipidemia control.

Authors:  Na-Qiong Wu; Jian-Jun Li
Journal:  Chronic Dis Transl Med       Date:  2016-06-28

4.  Patterns of statin non-prescription in patients with established coronary artery disease: A report from a contemporary multicenter Japanese PCI registry.

Authors:  Mitsuaki Sawano; Shun Kohsaka; Takayuki Abe; Taku Inohara; Yuichiro Maekawa; Ikuko Ueda; Koichiro Sueyoshi; Masahiro Suzuki; Shigetaka Noma; Yohei Numasawa; Hiroaki Miyata; Keiichi Fukuda; Kim G Smolderen; John A Spertus
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

5.  The Marine Microalga, Tisochrysis lutea, Protects against Metabolic Disorders Associated with Metabolic Syndrome and Obesity.

Authors:  Claire Mayer; Léo Richard; Martine Côme; Lionel Ulmann; Hassan Nazih; Benoît Chénais; Khadija Ouguerram; Virginie Mimouni
Journal:  Nutrients       Date:  2021-01-28       Impact factor: 5.717

6.  Novel Role for Matrix Metalloproteinase 9 in Modulation of Cholesterol Metabolism.

Authors:  Samuel Hernandez-Anzaldo; Vesna Brglez; Bianca Hemmeryckx; Dickson Leung; Janos G Filep; Jean E Vance; Dennis E Vance; Zamaneh Kassiri; Roger H Lijnen; Gérard Lambeau; Carlos Fernandez-Patron
Journal:  J Am Heart Assoc       Date:  2016-09-30       Impact factor: 5.501

7.  Association between serum non-high-density lipoprotein cholesterol and cognitive dysfunction after acute ischemic stroke: a cross-sectional study.

Authors:  Yinghui Jiao; Tian Tian; Shasha Wei; Chengdong Wang; Lili Wu
Journal:  Braz J Med Biol Res       Date:  2020-10-30       Impact factor: 2.590
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.